World Allergy Organization Journal
Издатель: Elsevier · ISSN 1939-4551 · 17 статей
- In silico analysis of plant-derived allergens contained in the Milpa Diet
- Internet search volume reflects pollen exposure and seasonal allergic burden in Germany
- Aeroallergen sensitization and polysensitization in children with sickle cell disease undergoing allergy evaluation in French Guiana: A retrospective study
- Single-cell transcriptomic characterization of a TSLP-high basal epithelial state and its associated signals in chronic rhinosinusitis with nasal polyps
- Comment on "Targeting the CD74-MHC II axis with allergen-specific immunotherapy ameliorates pollen-induced allergic asthma"
- Overview of allergic disease: Severe asthma – WAO White Book on Allergy 2026 – 2.7
- Executive Summary of the 2025 World Allergy Organization Guidelines for Hereditary Angioedema
- Targeting the CD74-MHC II axis with allergen-specific immunotherapy ameliorates pollen-induced allergic asthma
- Clinical utility of Oriton IgE CHEMIPHAR™ for predicting skin prick test positivity in patients with allergic airway diseases
- Olive allergens under the microscope: Ole e 7 and Ole e 9 sensitization does not increase symptom severity or adverse reactions to subcutaneous allergen immunotherapy
- Biologic therapies for atopic diseases during pregnancy: A World Allergy Organization survey
- Landscape of hereditary angioedema in China: A multicenter cross-sectional questionnaire survey
- Fungal sensitization in China: Regional heterogeneity, diagnostic gaps, and implications for standardized allergy assessment
- Allergic rhinitis as a potentially modifiable contributor to small airway dysfunction and incomplete clinical remission in severe asthma
- Sleep quality and obstructive sleep apnoea risk in chronic spontaneous urticaria: Methodological and reporting considerations
- Overdiagnosis and underdiagnosis in mast cell activation syndrome: The diagnostic specificity paradox
- Wheal characteristics in chronic spontaneous urticaria and their association with omalizumab response